Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) shares skyrocketed in early trading Monday after Kleenex and Cottonelle maker Kimberly-Clark ( KMB) said it's buying the Tylenol maker in a $48.7 billion deal. 1

Kleenex parent company Kimberly-Clark buys Kenvue, maker of Tylenol, for $48.7B

Kimberly-Clark, which manufactures products like Kleenex and other products, is buying Kenvue, the maker of Tylenol, the company announced Monday, according to AP.

Kimberly-Clark Takeover Offers $48 Billion of Pain Relief to Tylenol-Maker Kenvue

The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.

Irving-based Kimberly-Clark buys Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is making a big move with a nearly $50 billion acquisition. The North Texas company plans to acquire Kenvue Inc., a personal care

Kimberly-Clark Agrees to Buy Kenvue, Maker of Tylenol, for $40 Billion

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a common pain reliever is linked to autism.

Kimberly-Clark Will Buy Tylenol Maker Kenvue in a $48.7 Billion Deal: ‘Powerful Next Step’

On Monday, Kimberly-Clark, the company behind Kleenex, Huggies and Kotex, agreed to acquire Kenvue, the owner of Tylenol, Band-Aid and Neutrogena, in a cash and stock deal valued at approximately $48.7 billion. The move will create one of the world’s largest consumer staples and health goods companies, per CNBC.
Managing Intellectual Property

Kirkland, Cravath lead on Kimberly-Clark’s $48.7bn deal with Kenvue

IP, M&A, life sciences and competition partners advised on deal that brings together brands such as ‘Huggies’ and ‘Kleenex’ with ‘Band-Aid’ and ‘Tylenol’
Feedback